#Clinical

Matthew Herder

cmrherder

. @GovCanHealth has authorized the $PFE / BioNTech Covid19 vaccine. https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730Here are a few first impressions: 1. The authorization is pursuant to section

Woke But Petty

marcformarc

I see a lot of people using words like abusive, gaslighting, or traumatizing to refer to people just being shitty or something bad happening. And I gotta say it’s really

Alex Berenson

AlexBerenson

Hey, if I tell you thalidomide causes birth defects, am I an "anti-medder"?No, of course not.SOME DRUGS ARE SAFE AND EFFECTIVE. OTHERS AREN'T.Vaccines are no different. Except no one is

Dr. Om Lakhani, MD, DNB (ENDO)

omlakhani

#MedTwitter #ClinicalPearl #Endotwitter Is your patient having persistently high TSH , despite increasing the dose of your thyroid medications ? The patient on the other hand is asymptomatic and the

Robert Peston

Peston

The big point about the first dose of the Oxford/AstraZeneca vaccine is that it massively reduces the risk of serious disease and hospitalisations. In the trials, no one given the

Dr. Makanaki

DrLotenna

#MedTwitter ,I'm curious, I want to know how almost everybody is now called 'Chief'. I've tried to get people to stop calling me that to no avail. I once asked

David Fisman

DFisman

I want to follow up on a thread I started but abandoned last night. I have been working on clinical prediction rules that predict death in folks with identified covid

Dr Darren Saunders

whereisdaz

And that, folks, is why we do Phase 3 trials... #vaccine #COVID #COVAX This is not unusual in trials, and it’s appropriate to proceed with caution. It’s a hold/pause, not

Jim Ritchie

ChorltonJim

Having missed both #dhss20 and #DHrewired20 this year, I need to improve my digital health CME. Lockdown 2.0 seems like a good time to propose #CCIOHomeSchool @ayesharahimCCIO @rijan44 @DrPeterMarc @NHSCCIO

Stephen V Liu

StephenVLiu

#WCLC20 Passionate plea to clinical investigators designing clinical trials by @jillfeldman4 at the @IASLC plenary. Eloquent articulation at some of the fundamental flaws in our research infrastructure. This is a

Mark Wardle

mwardle

There is no “properly” - only a set of options with various trades offs, so that is why options appraisal needed as part of process. Also, this isn’t purely a

Michael Larkin

ipanalysis

Booked a testing slot [yesterday] for the youngest [off school after two days back, b/c she had a temperature yesterday]. Went to the testing centre tonight with her. Slightly dystopian

Dr Katerina Kavalidou

KKavalidou

Always happy to review papers on #multimorbidity, within and outside #suicide research. But I always see the same pattern of issues/errors: multimorbidity is not used only for physical health conditions.

femdot.

femdotdotcom

ok boom so some context on that new rona stopper that pfizer & biontech dropped. this might be long, bare w/ me. for the sake of tweets lets call it

Ashish K. Jha, MD, MPH

ashishkjha

President Trump, advisor @SWAtlasHoover arguing there's lot of false coding of COVIDThis is junk newsLike junk food, junk news tastes good but has no nutritional valueSo what are the facts?Don't

Ritesh Banglani

banglani

Excellent analysis of the state of telemedicine in the US. Riffing off some of Nikhil's conclusions from an India perspective below. Disclaimer: I'm an investor and board member in @MFineCare,

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.